News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Two new treatments funded for blood disorders and cancers

Media release

Two new treatments funded for blood disorders and cancers

20 August, 2014

Up to 400 patients a year are likely to live longer as a result of PHARMAC funding two new medicines.

The medicines are azacitidine (Vidaza) and lenalidomide (Revlimid), which will be funded from 1 September.

Azacitidine is being funded for a group of blood disorders collectively known as myelodysplastic syndromes (MDS), and for two types of leukaemia (chronic myelomonocytic leukaemia and
MDS-associated acute myeloid leukaemia).

Lenalidomide will be funded for multiple myeloma, a type of blood cancer. It will be an alternative to the currently funded treatments bortezomib and thalidomide, and funded for use in patients
if these treatments fail.

Director of Operations Sarah Fitt says both new medicines have proven effectiveness and should lead to patients living longer. They are important additions to the tools that haematologists will
have to treat multiple myeloma, leukaemia and MDS.

“Clinical trials of azacitidine showed it nearly doubles the survival rate of people with MDS, compared to conventional treatment,” she says. “This is a significant improvement for this patient group,
who have had limited treatment options.

“In the case of lenalidomide, the aim of treatment is to delay disease progression and also to prolong life. The trials show that lenalidomide is effective in patients whose disease has progressed
after receiving previous treatments.”

Sarah Fitt says another benefit of lenalidomide is that it doesn’t have some of the side effects of the other funded treatments, which can be debilitating for patients. Bortezomib and thalidomide can
cause peripheral neuropathy, a condition that causes tingling, numbness and pain in hands and feet.

“So, as well as being an effective treatment, lenalidomide is less likely to cause debilitating peripheral neuropathy than the currently available treatments, so it may be a better treatment option for
some patients.”

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Anniversaries: Vivid Memories Four Years After Christchurch Quake

Four years ago, an earthquake that would change the lives of thousands shook Christchurch at 12.51 p.m. More>>

ALSO:

Environment 'n' Conservation: Slash Meets Tāne The Tuatara

Rock and Roll superstar and former Guns 'n' Roses guitarist Slash visited Zealandia Ecosanctuary along with collaborating band Myles Kennedy and the Conspirators. More>>

Foo Fighters: Exclusive Show In Support Of Music Foundation

Frontier Touring has today announced that the Foo Fighters will play a last minute intimate and exclusive benefit show at the Auckland Town Hall this Friday February 20 with all profits going to The New Zealand Music Foundation. More>>

ALSO:

Canterbury Quakes: Feedback Sought On Short-Listed Memorial Designs

Six short-listed designs for the Canterbury Earthquake Memorial have been released for public input... The Memorial will honour the victims of Canterbury’s earthquakes and acknowledge the suffering of all those who lived through them as well as the heroism of those who participated in the rescue and recovery operations. More>>

ALSO:

Celia Lashlie: Legacy Will Live On

Social justice advocate Celia Lashlie leaves a legacy that will continue to have a positive impact on the lives of New Zealanders for years to come, Labour Leader Andrew Little says. “Celia was a powerful voice for reason, sense and compassion. Her work, particularly with teenage boys, was ground-breaking." More>>

ALSO:

Obituary: Sad Farewell To PPTA Activist Robin Duff

Duff has been a long-time fixture of the association... Most recently Duff has been working hard to support Canterbury teachers through the quakes that devastated the region. More>>

ALSO:

Poroporoaki: Dr Apirana Tuahae Kaukapakapa Mahuika

Papa Api was a man of many great gifts and occupied a long list of roles including priest, teacher, scholar, politician, and leader. Chair of Te Runanganui o Ngati Porou, and a rangatira of his iwi... More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news